摘要
目的减少静脉药物配置缺陷,保证临床用药安全。方法成立静脉药物配置专项质量管理小组,对2012年1-6月发生的静脉药物配置缺陷进行分类分析,落实对应改进策略并循环检查。结果改进后,静脉药物配置缺陷率由0.040 9%降至0.005 4%,差异有统计学意义(P<0.01)。结论以质量管理小组进行静脉药物配置品质持续改善,有效降低静脉药物配置各环节缺陷,为临床用药安全提供保障。
Objective To reduce the intravenous admixture defects and ensure the safety of clinical medication. Methods The quality management team of intravenous admixture was established, the intravenous admixture de fects from January to June in 2012 were analyzed, and the improvement strategies was implemented and checked circularly. Results The rate of intravenous admixture defects dropped from 0. 040 9% to 0. 005 4% with an extremely significant difference （ P 〈 0. O1 ）. Conclusion It can provide the safety for clinical medicine by establishing the quality management team to sustain the improvement about the quality and reduce defects effectively in various stage of intravenous drugs configuration.
出处
《实用药物与临床》
CAS
2014年第8期1076-1079,共4页
Practical Pharmacy and Clinical Remedies
